Government signs agreement with BioNTech SE to provide up to 10,000 patients with precision cancer immunotherapies by 2030
NHS England’s new Cancer Vaccine Launch Pad aims to improve access to personalised treatments and clinical trials
BioNTech SE to set up laboratories and a regional hub in England to support the development of immunotherapies
https://www.gov.uk/government/news/major-agreement-to-deliver-new-cancer-vaccine-trials
Covid vaccine research now helping cancer patients
https://www.bbc.com/news/uk-england-merseyside-66096301
h/t A Deplorable Neanderthal